… venom immunotherapy is currently the most effective form of … The clinical efficacy of VIT can
be seen in the fact that it reduces … A recent multicenter study prospectively collected data on …

… systemic sting reactions from the risk of future serious SAR … : results from an EAACI multicenter
study. Allergy. 2000;55(11… clinical effectiveness of Hymenoptera venom immunotherapy…

… venom immunotherapy (VIT), with an efficacy of up to 98% in humans. Prospective clinical
data on VIT efficacy … VIT efficacy was determined by observing patients’ clinical reactions to re-…

… sensitized people will have a future systemic sting reaction (… between 8 and 20% from large
multicenter studies (12, 13). In … be a more accurate measure of clinical efficacy and seems to …

… In large multicenter studies, the frequency of SRs reactions … years and correlated with clinical
efficacy, although IgG4 levels … failure in honey bee venom immunotherapy. J Allergy Clin …

… , subcutaneous venom immunotherapy (VIT) is an effective and … efficacy of bee venom ILIT
in a multicenter phase I/II clinical … potential clinical benefits of this novel immunotherapy, it also …

… Moreover, a French multicenter study was performed on Ves v … Moreover, the use of single
allergens in BAT in the future … diagnostics to direct in venom immunotherapy: important steps …

… with high risks of future bee and/or wasp stings, such as … supply Hymenoptera venom
extracts for clinical applications. … 4 C, through the entire observation period of approximately 6 …

… Future research needs to build on these recent advances to … In a prospective, observational
study across 3 centers, ultra-rush … of hymenoptera venom immunotherapy on clinical course, …

… prospective multicenter study observed that vespid venom … discontinuation of venom
immunotherapy for bee was 16% … , there is a sole prospective longitudinal observational study in …